VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXA81EZ: VAERS reports

20 VAERS reports list lot ABXA81EZ as a Novartis Vaccines Meningococcal vaccine, received between 2021-04-01 and 2023-10-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)820%
Neurological718%
Injection-site / Local reaction718%
Dermatological (non-injection-site)512%
Allergic / Anaphylactic410%
Musculoskeletal410%
Cardiac / Cardiovascular25%
Gastrointestinal25%
Thrombotic / Hematological12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Illinois3
Wisconsin2
Indiana2
Texas2
Arizona2
Utah1
Kentucky1
Iowa1
Missouri1
Pennsylvania1
Oregon1

Reports by month received

2021-041
2021-053
2021-062
2021-072
2021-091
2021-121
2022-027
2022-041
2022-121
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.